Early increase of CD4+ CD45RA+ and CD4+ CD95- cells with conserved repertoire induced by anti-retroviral therapy in HIV-infected patients

Clinical and Experimental Immunology

Volumn 111, Issue 1, 1998, Pages 3-11

  Silvestri, G ^a,d   Munoz Calleja, C ^a   Bagnarelli, P ^a   Piedimonte, G ^b   Clementi, M ^c   Montroni, M ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

^d c/o Ospedale Generale Regionale ^*  (Italy)

Author keywords

CD4+; CD45RA RO; CD95 Fas; HIV; Lymphocytes; TCR

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD45 ANTIGEN; DIDANOSINE; T LYMPHOCYTE RECEPTOR; ZIDOVUDINE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIREMIA;

ADULT; ANTI-HIV AGENTS; ANTIGEN PRESENTATION; ANTIGENS, CD45; ANTIGENS, CD95; CD4-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MALE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS;

EID: 0031951027     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00464.x     Document Type: Article

References (56)

1. Ho DD, Pomerantz, RJ, Kaplan JC. Pathogenesis of infection with human immunodeficiency virus. N Engl J Med 1987; 317:278-86.
2. Pantaleo G, Graziosi C, Fauci AS. Immunopathogenesis of human immunodeficiency virus type 1 infection. N Engl J Med 1993; 328: 327-35.
3. + T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann Int Med 1990; 113:438-43.
4. Schooley RT. Correlation between viral load measurements and outcome in clinical trials of antiviral drugs. AIDS 1995; 9 (S2):S15-S19.
5. O'Brien WA, Hartigan PM, Martin D et al. Changes in plasma HIV-1 RNA and CD4 lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996; 334:426-31.
6. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science (Wash. DC) 1996; 272:1167-70.
7. Katzenstein DA, Hammer SM, Hughes MD et al. The relation of virological and immunological markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200-500 CD4 cells per cubic millimeter. N Engl J Med 1996; 335:1091-8.
8. Wei X, Ghosh SK, Taylor ME et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995; 373:117-22.
9. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373:123-7.
10. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science (Wash. DC) 1996; 271:1582-6.
11. 4+ T cell turnover. Science (Wash. DC) 1996; 274:1543-7.
12. Hammer SM, Katzenstein DA, Hughes MD et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. N Engl J Med 1996; 335:1081-90.
13. Roos MTL, Miedema F, Knot M et al. T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects. J Infect Dis 1995; 171:531-6.
14. + T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nature Med 1997; 5:533-40.
15. Bagnarelli P, Menzo S, Valenza A et al. Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. J Virol 1992; 66:7328-35.
16. Menzo S, Bagnarelli P, Giacca M, Manzin A, Varaldo PE, Clementi M. Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription polymerase chain reaction. J Clin Microbiol 1992; 30:1752-7.
17. + cell counts, and HIV-1 production by cells. Science (Wash. DC) 1996; 271:670-1.
18. Sanders ME, Makgoba MV, Shaw S. Human naive and memory T cells. Immunol Today 1988; 9:195-9.
19. Beverly P. Immunological memory in T cells. Curr Opin Immunol 1991; 3:355-61.
20. Sprent J, Tough DF. Lymphocyte life-span and memory. Science 1994; 265:1395-400.
21. Tough DF, Sprent J. Turnover of naive- and memory-phenotypeT cells. J Exp Med 1994; 179:1127-35.
22. Gruters RA, Terpstra FG. De Goede RE et al. Immunological and virological markers in individuals progressing from seroconversion to AIDS. AIDS 1991; 5:837-44.
23. Bass HZ, Hardy WD, Mitsuyasu RT, Wang YX, Cumberland W, Fahey JL. Eleven lymphoid phenotypic markers in HIV-infection: selective changes induced by Zidovudine treatment. J Acquir Immune Defic Syndr 1992; 5:890-7.
24. + cells are not selectively decreased in chronic HIV disease. J Aequir Immune Defic Syndr 1994; 7:665-71.
25. + lymphocytes in human immunodeficiency virus type 1 infection is associated with selective depletion of this lymphocyte subset. Blood 1996; 88:2626-33.
26. Roederer M, Gregson Dubs J, Anderson MT, Raju PA, Herzenberg LA, Herzenberg LA. CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest 1995; 95:2061-6.
27. Lynch DH, Ramsdell F, Alderson MR. Fas and FasL in the homeostatic regulation of immune response. Immunol Today 1995; 16:569-74.
28. + T cells. Proc Natl Acad Sci USA 1996; 93:11014-8.
29. Oyaizu N, McCloskey TW, Than S, Hu R, Pahwa S. Mechanism of apoptosis in peripheral blood mononuclear cells of HIV-infected patients. Adv Exp Med Biol 1995; 374:101-14.
30. Maldarelli F, Sato H, Berthold E, Orenstein J, Martin MA. Rapid induction of apoptosis by cell-to-cell transmission of human immunodeficiency virus type 1. J Virol 1995; 69:6457-65.
31. Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA, Herzenberg LA. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med 1995; 181:2029-36.
32. + cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. Blood 1996; 87:4959-66.
33. Gehri R, Hahn S, Rothen M, Steuerwald M. Neusch R. Erb P. The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells. AIDS 1996; 10:9-16.
34. Badley AD, McElhinny JA, Leihson PJ, Lynch DH, Alderson MR, Paya CV. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J Virol 1996; 70:199-206.
35. Gougeon ML, Lecoeur H. Dulioust A et al. Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J Immunol 1996; 156:3509-20.
36. McCloskey TW, Oyaizu N, Kaplan M, Pahwa S. Expression of the Fas antigen in patients with human immunodeficiency virus. Cytometry 1995; 22:111-4.
37. Baumler CB, Bohler T, Herr I, Benner A, Krammer PH, Debatin KM. Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1 infected children. Blood 1996; 88: 1741-6.
38. + T cells of the virus-positive twins. Proc Natl Acad Sci USA 1994; 91:1529-33.
39. Posnett DN, Kabak S, Hodtsev AS, Goldberg EA, Asch A. T-cell antigen receptor V beta subsets are not preferentially deleted in AIDS. AIDS 1993; 7:625-31.
40. Boyer V, Smith LR, Ferre F et al. T cell receptor V beta repertoire in HIV-infection individuals: lack of evidence for selective V beta deletion. Clin Exp Immunol 1993; 92:437-41.
41. + T lymphocytes and functional integrity of T-cell repertoire during acute HIV syndrome. AIDS 1995; 9:547-54.
42. Cossarizza A, Ortolani C, Mussini C et al. Massive activation of immune cells with an intact T cell repertoire in acute human immunodeficiency virus syndrome. J Infect Dis 1995; 172:105-12.
43. Dobrescu D, Kabak S, Mehta K et al. Human immunodeficiency virus 1 reservoir in CD4(+) T cells is restricted to certain V beta subsets. Proc Natl Acad Sci USA 1995; 92:5563-7.
44. Dobrescu D, Ursea B, Pope M, Asch AS, Posnett DN. Enhanced HIV-1 replication in V beta 12 T cells due to human CMV in monocytes: evidence for a putative herpesvirus superantigen. Cell 1995; 82:753-63.
45. Piatak M, Saag MS, Yang LC et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science (Wash. DC) 1993; 259:1749-54.
46. + T-helper cells. Am J Pathol 1992; 140:15-22.
47. Pantaleo G, Graziosi C, Demarest JF et al. HIV-infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993; 362:355-9.
48. Haase AT, Henry K, Zupancic M et al. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science (Wash. DC) 1996; 274:985-9.
49. + T lymphocytes in spleens of human immunodeficiency virus-positive patients. J Virol 1995; 69:4737-45.
50. Kelleher AD, Carr A, Zaunders J, Cooper DA. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, Ritonavir. J Infect Dis 1996; 173:321-9.
51. + T cell homeostasis and function in advanced HIV disease. Science 1997; 277:112-6.
52. Pinto L, Covas MJ, Victorino RM. Loss of CD45RA and gain of CD45RO after in vitro activation of lymphocytes from HIV-infected patients. Immunology 1991; 73:147-50.
53. Banda NK, Bemier J, Kurahara DK et al. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 1990; 176:1099-106.
54. + T cell populations. Eur J Immunol 1995; 25:2907-16.
55. Westendorp MO, Frank R, Ochsenbauer C et al. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995; 375:497-500.
56. Mura-Cacho CA, Pantaleo G, Fauci AS. Analysis of apoptosis in lymph nodes of HIV-infected persons: intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J Immunol 1995; 154:5555-66.